These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Autoantibodies in liver diseases: interpretation and pathogenic importance]. Pons Romero F; Casafont F Gastroenterol Hepatol; 1996; 19(6):326-33. PubMed ID: 8754423 [No Abstract] [Full Text] [Related]
9. High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis. Galbraith RM; Smith M; Mackenzie RM; Tee DE; Doniach D; Williams R N Engl J Med; 1974 Jan; 290(2):63-9. PubMed ID: 4127959 [No Abstract] [Full Text] [Related]
10. [Possible use of immunofluorescence in chronic agressive hepatitis]. Storch W; Emmrich R Dtsch Z Verdau Stoffwechselkr; 1973; 33(3):119-23. PubMed ID: 4599279 [No Abstract] [Full Text] [Related]
11. Australia antigen and autoantibodies in chronic hepatitis. Vischer TL Br Med J; 1970 Jun; 2(5711):695-8. PubMed ID: 4988026 [TBL] [Abstract][Full Text] [Related]
12. [Australia antigen in chronic aggressive hepatitis and liver cirrhosis. Its significance for the etiology and pathogenesis of chronic inflammatory liver diseases]. Müller R; Kalden JR; Baruth B; Deicher H Dtsch Med Wochenschr; 1972 Mar; 97(10):369-75. PubMed ID: 4622158 [No Abstract] [Full Text] [Related]
16. [Significance of immune histological findings for indication of immunosuppressive therapy in chronic aggressive hepatitis]. Storch W; Emmrich R; Petzold H Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:174-6. PubMed ID: 4580507 [No Abstract] [Full Text] [Related]